Tatsuo Ikei

Title: Innovations by Tatsuo Ikei

Introduction

Tatsuo Ikei is a notable inventor based in Ikoma, Japan. He has made significant contributions to the field of ophthalmology, particularly through his innovative work on ophthalmic solutions. With a total of 4 patents to his name, Ikei's inventions focus on enhancing the effectiveness and safety of eye care products.

Latest Patents

One of Ikei's latest patents involves an ophthalmic solution comprising Diquafosol. This invention addresses the formation of insoluble precipitates that can occur during the storage of Diquafosol ophthalmic solutions. It also tackles the deterioration of filtration performance during the production process. By incorporating a chelating agent at a concentration of 0.0001 to 1% (w/v), Ikei's formulation has been shown to reduce eye irritation and enhance preservative effectiveness compared to solutions without a chelating agent. This innovation ensures that the physicochemical properties of the solution remain stable throughout production, distribution, and patient storage.

Career Highlights

Tatsuo Ikei is associated with Santen Pharmaceutical Co., Ltd., a company renowned for its commitment to eye care. His work has significantly impacted the development of safer and more effective ophthalmic products.

Collaborations

Ikei has collaborated with notable colleagues, including Mikiko Saito and Masatsugu Nakamura. Their combined expertise has contributed to the advancement of ophthalmic solutions and the overall improvement of patient care.

Conclusion

Tatsuo Ikei's innovative contributions to ophthalmology through his patents demonstrate his commitment to enhancing eye care solutions. His work not only addresses critical issues in the formulation of ophthalmic products but also prioritizes patient safety and comfort.